A pregnant physician who was denied a Covid-19 vaccine is suing the Trump administration alongside a group of leading doctors associations, charging that the administration sought to “desensitize the public to anti-vaccine and anti-science rhetoric”, according to their attorney.
The lawsuit specifically takes aim at health secretary Robert F Kennedy’s unilateral decision to recommend against Covid-19 vaccines for pregnant women and healthy children.
Kennedy’s announcement circumvented expert scientific review panels and flouted studies showing pregnant women are at heightened risk from the virus, and made it more difficult for some to get the vaccine.
“This administration is an existential threat to vaccination in America, and those in charge are only just getting started,” said Richard H Hughes IV, partner at Epstein Becker Green and lead counsel for the plaintiffs in a statement.
The American Academy of Pediatrics, American College of Physicians and American Public Health Association are among a list of leading physicians associations named as plaintiffs in the lawsuit.
“If left unchecked, secretary Kennedy will accomplish his goal of ridding the United States of vaccines, which would unleash a wave of preventable harm on our nation’s children,” said Hughes. “The professional associations for pediatricians, internal medicine physicians, infectious disease physicians, high-risk pregnancy physicians, and public health professionals will not stand idly by as our system of prevention is dismantled. This ends now.”
In late May, Kennedy announced that the Centers for Disease Control and Prevention (CDC) would no longer recommend Covid-19 vaccines for healthy children or pregnant women. The announcement, made on social media, contradicted a raft of evidence showing pregnant women and infants are at especially high-risk from the disease, including from the administration’s own scientific leaders.
In June, Kennedy went further by firing all 17 sitting members of a key vaccine advisory panel to the CDC. The advisory panel is a key link in the vaccine distribution pipeline, helping to develop recommendations insurers use when determining which vaccines to cover.
That panel met for the first time in late June. Members announced they would review both the childhood vaccine schedule and any vaccines that had not been formally reviewed in seven years. They also recommended against a long-vilified vaccine preservative, in spite of a lack of evidence of harm.
The news comes amid the largest annual measles case count in 33 years, and amid reports of more parents seeking early vaccination for their children, fearing vaccines will go into shortage or no longer be covered by insurance.
